Keywords
in silico molecular docking
inhibition of MDR1
kinase cascades
natural phaeosphaeride A
oncology
X-ray diffraction analysis
Abstract
The structure of the lead compound, a natural phaeospha- eride A derivative AV-6, (2S,3R,4R)-3-hydroxy-6-methoxy-3-methyl-7-methylene-2-pentyl-4-pyrrolidin-1-yl-3,4,6,7-tetrahydropyrano[2,3-c]pyrrol-5(2H)-one, was unambiguously determined by X-ray crystallography. When modeling in silico the interaction of AV-6 with targets in kinase cascades, high values of the binding energy (below -9 kcal mol-1) for some protein targets were shown. Our results identified that MAPK11, MAPK12 and AKT1 could be targets of AV-6.
References
1.
Dolomanov O.V., Bourhis L.J., Gildea R.J., Howard J.A., Puschmann H.
Journal of Applied Crystallography,
2009
2.
Abzianidze V., Moiseeva N., Suponina D., Zakharenkova S., Rogovskaya N., Laletina L., Holder A.A., Krivorotov D., Bogachenkov A., Garabadzhiu A., Ukolov A., Kosorukov V.
Pharmaceuticals,
2022
3.
Maloney K.N., Hao W., Xu J., Gibbons J., Hucul J., Roll D., Brady S.F., Schroeder F.C., Clardy J.
Organic Letters,
2006
4.
Shaw A.S., Filbert E.L.
Nature Reviews Immunology,
2009
5.
Sebolt-Leopold J.S., Herrera R.
Nature Reviews Cancer,
2004
6.
Abzianidze V.V., Efimova K.P., Poluektova E.V., Trishin Y.G., Kuznetsov V.A.
Mendeleev Communications,
2017
7.
Zakharenkova S.A., Abzianidze V.V., Moiseeva N.I., Lukina D.S., Chistyi L.S., Krivorotov D.V., Trishin Y.G.
Mendeleev Communications,
2021
8.
9.
Ellert-Miklaszewska A., Poleszak K., Kaminska B.
Future Medicinal Chemistry,
2017
10.
Wilson A.L., Plebanski M., Stephens A.N.
Current Medicinal Chemistry,
2018